A. Marusyk
Molecular Biology · 2009–2020
A researcher in the Science corpus: 4 papers; trusts 5 researchers and is trusted by 11 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 82 citations into it; #7,462 of 17,773 by trust here, #9,476 by citations
- Oncology — 78 citations into it; #294 of 1,698 by trust here, #641 by citations
- Cancer Research — 73 citations into it; #372 of 1,780 by trust here, #727 by citations
Whom A. Marusyk trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Robert A. Gatenby
- Carlo C. Maley
- K. Polyak
- Rakesh K. Jain
- Bert Vogelstein
- J. Dick
- P. Chesson
- R. May
- P. Amarasekare
- Robert James Gillies
Who trusts A. Marusyk overall
- V. Plaks
- Arthur W. Lambert
- Richard J. Chen
- D. Pattabiraman
- Jie Zheng
- Ming Y. Lu
- Computational Pan-Genomics Consortium
- K. Polyak
- Niwen Kong
- Drew F. K. Williamson
Papers from A. Marusyk's perspective
Ordered by how strongly the researchers A. Marusyk trusts endorse each paper. Same corpus, a different order for every researcher.
- Prospective identification of tumorigenic breast cancer cells (Proceedings of the National Academy of Sciences of the United States of America)
- Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution (Nature)
- Signatures of mutational processes in human cancer (Nature)
- A chromatin-mediated reversible drug tolerant state in cancer cell subpopulations (Cell)
- Stem cell concepts renew cancer research. (Blood)
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses (Science)
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme (Science)
- The hallmarks of cancer (RNA Biology)
- Mutational landscape and significance across 12 major cancer types (Nature)
- A microenvironmental model of carcinogenesis (Nature Reviews. Cancer)
Their papers
- Intra-tumour heterogeneity: a looking glass for cancer? (2012) — 1,979 citations
- Intratumor heterogeneity: the Rosetta stone of therapy resistance (2020) — 807 citations
- The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors. (2011) — 890 citations
- Tumor heterogeneity: causes and consequences (2009) — 1,616 citations